Free Newsletter
FDA warned tainted syringe maker
FDA sent a warning letter to a North Carolina syringe manufacturer, notifying of "several significant violations" in its quality control system, two years before its needles triggered an outbreak of illnesses that prosecutors say led to at least five deaths, the News & Observer reports. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: